Novus Therapeutics Q3 EPS $(0.22) Up From $(0.37) YoY

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.22) per share. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year.

Benzinga · 11/13/2019 12:38

Novus Therapeutics (NASDAQ:NVUS) reported quarterly losses of $(0.22) per share. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year.